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Perfluorooctanesulfonate 
(PFOS)-induced Sertoli cell injury 
through a disruption of F-actin 
and microtubule organization is 
mediated by Akt1/2
Ying Gao1, Haiqi Chen1, Xiang Xiao1,2, Wing-yee Lui3, Will M. Lee3, Dolores D. Mruk1 & 
C. Yan Cheng  1
PFOS (perfluorooctanesulfonate, or perfluorooctane sulfonic acid) is an anthropogenic fluorosurfactant 
widely used in consumer products. While its use in Europe, Canada and the U.S. has been banned 
due to its human toxicity, it continues to be used in China and other developing countries as a global 
pollutant. Herein, using an in vitro model of Sertoli cell blood-testis barrier (BTB), PFOS was found to 
induce Sertoli cell injury by perturbing actin cytoskeleton through changes in the spatial expression 
of actin regulatory proteins. Specifically, PFOS caused mis-localization of Arp3 (actin-related protein 
3, a branched actin polymerization protein) and palladin (an actin bundling protein). These disruptive 
changes thus led to a dis-organization of F-actin across Sertoli cell cytosol, causing truncation of actin 
microfilament, thereby failing to support the Sertoli cell morphology and adhesion protein complexes 
(e.g., occludin-ZO-1, CAR-ZO-1, and N-cadherin-ß-catenin), through a down-regulation of p-Akt1-S473 
and p-Akt2-S474. The use of SC79, an Akt1/2 activator, was found to block the PFOS-induced Sertoli cell 
injury by rescuing the PFOS-induced F-actin dis-organization. These findings thus illustrate PFOS exerts 
its disruptive effects on Sertoli cell function downstream through Akt1/2. As such, PFOS-induced male 
reproductive dysfunction can possibly be managed through an intervention on Akt1/2 expression.
PFOS is a global pollutant and an environmental toxicant, widely used as a fabric protector, serving as a stain 
repellant in drapery, carpets and clothing. Its use in consumer products has been discontinued and banned in 
Europe, Canada and the U.S. since the 2000s due to its health risks associated with human, wildlife and animal 
exposure including reduced fetal growth, endocrine disruption, reproductive dysfunction, and neonatal mor-
tality1–4. However, epidemiologic evidence does not support a causal association between PFOS exposure and 
cancer risk in humans5. Nonetheless, in utero exposure to PFOS adversely affect the fetal synthesis and secretion 
of reproductive hormones (e.g., testosterone, estradiol, and inhibin B) in humans6. Since the half-life of PFOS 
and its related compound PFOA (perfluorooctanoic acid) is relatively long, at 5.4-yr and 3.8-yr, respectively7, 8, 
even low-dose exposure to PFOS and its related compounds can accumulate in the body over an extended period 
of time. At present, studies in rodents have generally supported the notion that PFOS perturbs testis function, 
such as by inducing Sertoli cell injury and disrupting Leydig cell steroidogenic function9–12. A recent study from 
our laboratory has shown that the PFOS-mediated Sertoli cell injury that impedes blood-testis barrier (BTB) 
function using an in vitro model of primary Sertoli cells is through a disruption of actin-based cytoskeleton in 
Sertoli cells, involving p-FAK-Y40713, which is an activated form of FAK earlier shown to be involved in BTB 
remodeling during spermatogenesis14. The notion that FAK is involved in PFOS-mediated Sertoli cell injury was 
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further confirmed by using an endogenous miRNA specific for FAK, miR-135b, which was found to perturb the 
Sertoli TJ-permeability barrier alone, and also worsened PFOS-induced TJ-barrier disruption13. However, over-
expression of a constitutive active phosphomimetic mutant of p-FAK-Y407, namely p-FAK-Y407E, by mutating 
Tyr(Y)-407 to Glu(E)-407, in Sertoli cells could protect these cells from the damaging effects of PFOS13.
Recent studies have shown that the Sertoli cell BTB function is mediated by mTORC1 complex through 
rpS6, involving Akt1/2 downstream, which in turn modulates F-actin organization in Sertoli cells15, but also 
involving MMP9 activation16. Other studies also support the involvement of FAK in mTOR signaling17, and 
the involvement of MMP2 and FAK in Akt signaling18. In order to better understand the signaling pathway of 
FAK-mediated rescue function during PFOS-induced Sertoli cell injury, we sought to examine the involvement 
of Akt in PFOS-mediated Sertoli cell injury, and its functional relationship with p-FAK-Y407. This mechanistic 
study thus provides additional insight on the molecular mechanism by which PFOS causes reproductive dysfunc-
tion in males through its disruptive effects on the Sertoli cell of the mammalian testis.
Results
PFOS perturbs TJ- and basal ES-protein localization in Sertoli cells – an involvement of 
p-Akt1/2? Sertoli cells isolated from 20-day-old rat testes were cultured in vitro for 3 days to form a cell 
epithelium with an established functional TJ-barrier, which mimicked the Sertoli cell BTB in vivo19–22. This in vit-
ro-based system has been widely used by investigators to study BTB dynamics23–29, and many of the findings were 
subsequently confirmed by studies in vivo30–33. Thereafter, these cells were treated with PFOS at 10, 20 or 50 µM 
for 24 hr. It was noted that PFOS perturbed the Sertoli cell TJ-permeability barrier function dose-dependently 
with PFOS at 50 µM was more effectively to perturb the TJ function than at 20 µM (Fig. 1A). The range of PFOS 
concentration at 20–50 µM (i.e., at ~10–25 µg/ml) used in our study herein was shown not to be cytotoxic as 
recently reported from our laboratory, and no cytotoxicity was found at concentration up to 100 µM13. At present 
the acceptable daily intake (ADI) of PFOS is 150 ng/kg/day (for a review, see ref. 34). But since PFOS has a human 
elimination half-life of 5.4-year7, 8, a considerable level of PFOS could build up in humans in particular among 
industrial workers such as those who utilize PFOS for manufacturing of stain resistant carpets and fabrics.
Lysates from Sertoli cells at specified time points were then obtained for immunoblotting using correspond-
ing specific antibodies which were characterized earlier in our laboratory (Table 1)35, 36. The steady-state levels 
of TJ-proteins occludin and CAR, and basal ES-proteins N-cadherin and ß-catenin, branched actin polymer-
ization protein Arp3, barbed end capping and bundling protein Eps8, and actin nucleation protein formin 1 
were not perturbed following PFOS treatment, but TJ-adaptor protein ZO-1 and actin bundling proteins palla-
din and plastin 3 were down-regulated (Fig. 1B; Figure S1A). More important, considerable down-regulation of 
p-Akt1-T308, p-Akt1-S473, and p-Akt2-S474 were noted, but not total Akts including 1–3 (Fig. 1B; Figure S1A). 
The down-regulation of p-FAK-Y407, but not total FAK, was also noted (Fig. 1B), consistent with an earlier 
report13. We also detected no changes in the expression EB1 (a plus (+)-end tracking protein, +TIP, of MT, 
known to stabilize MT37) but a down-regulation on the expression of detyrosinated α-tubulin (i.e., removal of 
C-terminal Tyr by exposing Glu as the N-terminal residue known to stabilize MT, making MT less dynamic38). 
Gross mis-localization of TJ proteins occludin, CAR and ZO-1, as well as basal ES proteins N-cadherin and 
ß-catenin at the Sertoli cell-cell interface was also noted wherein these proteins no longer tightly associated with 
the cell cortical zone, but internalized and moved into the cell cytosol (Fig. 1C; Figure S1B). These changes thus 
de-stabilized the Sertoli cell barrier function.
PFOS perturbs Sertoli cell TJ-barrier function through changes in the spatial expression of actin 
binding and regulatory proteins. Since the TJ- and basal ES-proteins that displayed mis-localization at 
the Sertoli cell-cell interface noted in Fig. 1C all utilized F-actin for attachment, we next examined any changes in 
the F-actin organization in Sertoli cells following PFOS treatment. As expected, F-actin organization was grossly 
affected by PFOS treatment in which long stretches of actin microfilaments no longer laid across the Sertoli cell 
cytosol in an organized fashion as noted in control cells (left column), they became truncated, and in some cells 
they were also branched in two different experiments shown in the middle and right columns (Fig. 2). These 
changes in actin organization appeared to be the result of changes in spatial localization of branched actin polym-
erization protein Arp3 and actin bundling protein palladin which confer actin microfilaments into a bundled 
configuration, leading to actin filament bundles into a disorganized branched network. For instance, Arp3 no 
longer localized mostly at the cell-cell interface, but re-localized and moved into the cell cytosol (Fig. 2). Palladin 
also no longer stretched across the Sertoli cell cytosol to organize actin filaments into bundles as seen in controls, 
instead, paladin retracted from cell cytosol and found closer to the cell nuclei following PFOS treatment (Fig. 2). 
p-FAK-Y407, a known TJ regulator in the testis14 also considerably mis-localized in which they no longer found 
at the Sertoli cell-cell interface, but all diffusely localized in the cell cytosol (Fig. 2).
Rescue of PFOS-induced Sertoli cell TJ-barrier disruption by SC79, an activator of Akts through 
changes in the re-distribution of BTB-associated proteins. Recent studies have shown that Sertoli 
cell TJ-barrier disruption is mediated downstream via Akt1/2 through a down-regulation of p-Akt1-S473 and 
p-Akt2-S47415. We speculated an induction of p-Akt1/2 via the use of a membrane permeable Akt phospho-
rylation activator SC7939 might prevent the PFOS-mediated Sertoli cell TJ-permeability disruption, and might 
also rescue the PFOS-induced mis-localization of TJ- and basal ES-proteins at the Sertoli cell-cell interface. 
Indeed, the use of SC79 was found to block the PFOS-induced down-regulation of ZO-1, palladin, p-Akt1-T308 
and p-Akt1-S473 (but not p-Akt2-S474) (Fig. 3A; Figure S2A). It is of interest to note that SC79 itself activated 
p-Akt1-T308 and p-Akt1-S473 in DMSO-vehicle control group (Fig. 3A lane 1 vs. lane 3). However, SC79 per 
se had no apparent effects on the Sertoli cell TJ-permeability barrier function (Fig. 3B). But SC79 blocked the 
PFOS-induced Sertoli cell TJ barrier disruption when the barrier function was monitored across the Sertoli cell 
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Figure 1. PFOS perturbs Sertoli cell BTB function through changes in the expression and/or localization 
of proteins at the immunological barrier. Sertoli cells cultured on Matrigel-coated bicameral units, dishes or 
coverslips were treated on day 3 with 10, 20 or 50 μM PFOS for 24 hr. Thereafter, cells were washed twice with 
PBS to remove residual PFOS and terminated for immunoblotting (IB) or IF on day 4. (A) Typical results of 
a TER experiment that monitored the effects of PFOS, at 20 µM and 50 µM vs. vehicle control (DMSO) on the 
Sertoli cell TJ-permeability barrier. Each data point is a mean ± SD of triplicate units from an experiment, 
which was repeated 3 times and yielded similar results. **P < 0.01 by Student’s t-test compared between PFOS-
treated and control cells. (B) Immunoblot analysis to assess the effects of PFOS on the expression of TJ proteins: 
occludin, CAR and ZO-1; basal ES proteins: N-cadherin and β-catenin; actin regulatory proteins: Arp3, Eps8, 
palladin, formin 1 and plastin 3; signaling molecules: activated Akts: p-Akt1-T308, p-Akt1-S473, pAkt2-S474 
vs. Akts (including Akt1, 2 and 3), and activated FAK: p-FAK-Tyr407 vs. FAK; MT regulatory proteins: EB1 and 
detyrosinated α-tubulin. Actin and α-tubulin served as protein loading controls. PFOS was found to down-
regulate p-Akt1-T308, p-Akt1-S473, p-Akt2-S474 and p-FAK-Tyr407. Composite data of immunoblottings are 
shown in Figure S1A; and uncropped blots are shown in Figure S4. (C) Immunofluorescence analysis to assess 
the effects of PFOS at 20 µM and 50 µM vs. control on the distribution of TJ proteins: occludin, CAR and ZO-1; 
basal ES proteins: N-cadherin and β-catenin. PFOS caused internalization of TJ and basal ES proteins in Sertoli 
cells in which these proteins no longer tightly localized at the Sertoli cell-cell interface. Occludin and CAR at 
the cell-cell interface (annotated by white arrowheads) were diminished following PFOS treatment (yellow 
arrowheads). For ZO-1, N-cadherin and ß-catenin, these proteins were localized tightly at the cell-cell interface 
(white brackets) but were considerably internalized, diffusing away from the cell cortical zone (yellow brackets). 
Sertoli cell nuclei were visualized by DAPI. Composite analyzed data are shown in Figure S1B. Scale bar, 30 μm.
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epithelium on Matrigel-coated bicameral units (Fig. 3B). The ability of SC79 to rescue Sertoli cells from the 
disruptive effects of PFOS onto the TJ-barrier function was mediated through changes in the re-distribution of 
TJ-proteins CAR and ZO-1, as well as basal ES-proteins N-cadherin and β-catenin since SC79 treatment man-
aged to re-localize these BTB-associated proteins back to the Sertoli cell-cell interface compared to PFOS-treated 
cells without SC79 pre-treatment (Fig. 3C; Figure S2B). These findings thus support the notion that PFOS exerts 
its disruptive effects on the Sertoli cell-TJ barrier function via p-Akt signaling protein involving p-Akt1-T308 
and p-Akt1-S473 but not p-Akt2-S474. Furthermore, this disruptive effect can be blocked via the use of an Akt 
activator SC79.
Rescue of PFOS-induced Sertoli cell TJ-barrier disruption by SC79 through changes in the 
organization of actin-based cytoskeleton. We next examined the underlying molecular mechanism 
by which SC79, the activator of Akt, blocked the PFOS-mediated disruption on the Sertoli cell TJ-permeability 
barrier and by re-distributing BTB-associated proteins at the Sertoli cell-cell interface as noted in Fig. 3. As shown 
in Fig. 4 (top left panel), treatment of Sertoli cells with PFOS induced disorganization of actin microfilaments 
in Sertoli cells through changes in the spatial expression of Arp3, palladin and p-FAK-Y407 (a BTB regulator 
that confers BTB integrity) (Fig. 4, left panels). For instance, actin microfilaments across the Sertoli cell cytosol 
became truncated, no longer orderly organized and that stretched across the cell cytosol as found in control cells 
treated with DMSO alone (Fig. 4). The orderly alignment of actin microfilaments found in control cells were likely 
the result of spatial expression of Arp3 and p-FAK-Y407, mostly at the cell-cell interface and also palladin which 
conferred actin microfilaments their bundled configuration as noted in control cells (Fig. 4). Following PFOS 
treatment, Arp3 no longer localized prominently at the cell-cell interface but internalized, similar to p-FAK-Y407 
(see Figure S3), and palladin appeared to be retracted from the cell cytosol but localized closely to the cell nucleus 
(Fig. 4). However, treatment of SC79 prevented PFOS-induced changes in the spatial expression of Arp3 wherein 
this branched actin polymerization protein became localized more prominent at the Sertoli cell-cell interface, 
similar to control, instead of rapidly internalized as noted in PFOS-treated Sertoli cells (Fig. 4, Figure S3). This 
pattern of changes was similar to p-FAK-Y407 (Fig. 4, Figure S3). Furthermore, palladin was also found to stretch 
across the entire Sertoli cell cytosol in SC79 treated cells, blocking the PFOS-induced disruption of palladin 
Antibody Host species Vendor Catalog no.
Working dilution
IB IF/IHC
Actin Goat Santa Cruz Biotechnology sc-1616 1:300
Arp3 Mouse Sigma-Aldrich A5979 1:3000 1:50
Akt Rabbit Cell Signaling Technology 9272 1:1000
p-Akt T308 Rabbit Cell Signaling Technology 2965 1:1000
p-Akt1 S473 Rabbit Cell Signaling Technology 4060 1:1000
p-Akt2 S474 Rabbit Cell Signaling Technology 8599 1:1000
α-tubulin Mouse Abcam ab7291 1:500 (tissue) 1:300 (cell)
β-catenin Rabbit Thermo Fisher Scientific 71–2700 1:2000 1:100
CAR Rabbit Santa Cruz Biotechnology sc-15405 1:200 1:50
Detyrosinated α-tubulin Rabbit Abcam ab48389 1:1000 1:200
EB1 Mouse BD Biosciences 610534 1:200
EB1 Rabbit Santa Cruz Biotechnology sc-15347 1:200
Eps8 Mouse BD Biosciences 610143 1:5000 1:50
Formin 1 Mouse Abcam ab68058 1:500 1:50
FAK Mouse Millipore 05–537 1:1000
p-FAK-Tyr407 Rabbit Thermo Fisher Scientific 44–650G 1:1000 1:50
N-cadherin Mouse Thermo Fisher Scientific 33–3900 1:200 1:100
Occludin Rabbit Thermo Fisher Scientific 71–1500 1:250 1:100
Palladin Rabbit Proteintech 10853–1-AP 1:1000 1:100
Plastin 3 Rabbit Abcam ab137585 1:500
ZO-1 Rabbit Thermo Fisher Scientific 61–7300 1:250 1:100
Goat IgG-HRP Bovine Santa Cruz Biotechnology sc-2350 1:3000
Rabbit IgG-HRP Bovine Santa Cruz Biotechnology sc-2370 1:3000
Mouse IgG-HRP Bovine Santa Cruz Biotechnology sc-2371 1:3000
Rabbit IgG-Alexa Fluor 488 Goat Thermo Fisher Scientific A-11034 1:250
Mouse IgG-Alexa Fluor 488 Goat Thermo Fisher Scientific A-11029 1:250
Table 1. Antibodies used for different experiments in this study. Abcam, Cambridge, MA; Cell Signaling 
Technology, Danvers, MA; Santa Cruz Biotechnology, Santa Cruz, CA; Sigma-Aldrich, St. Louis, MO; 
Invitrogen, Life Technologies, Carlsbad, CA; Proteintech, Chicago, IL; BD Biosciences, San Jose, CA; Millipore 
Corp., Billerica, MA.
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Figure 2. Immunofluorescence analysis to assess the effects of PFOS on the organization of actin 
microfilaments in Sertoli cells via changes on the distribution of actin regulatory proteins. Sertoli cells cultured 
for 3 days were treated with 20 μM PFOS for 24 hr. Cells were then harvested and used for IF, and results from 
two different experiments were shown in middle and right columns vs. the control cells in the left column. PFOS 
caused truncation and defragmentation of F-actin network (green and gray). These changes in the organization 
of actin microfilaments were likely the result of changes in the spatial localization of several actin regulatory 
proteins. Arp3, a branched actin polymerization protein that effectively converted actin microfilaments 
into a branched/unbundled configuration no longer localized at the cell-cell interface to support F-actin 
dynamics at the cell cortical zone. Instead, Arp3 was internalized and found in the Sertoli cell cytosol, thereby 
impeding actin microfilaments to organize as long actin bundles stretched across the cell cytosol. Palladin, an 
actin cross-linking and bundling protein, no longer stretched across the Sertoli cell cytosol to maintain actin 
microfilaments across the Sertoli cells as found in control cells. Instead, palladin was retracted from the cell 
peripheries but concentrated to cell nuclei after PFOS treatment. p-FAK-Y407, a signaling protein shown to be 
involved in maintaining BTB integrity by maintaining F-actin network in Sertoli cells as actin filament bundles 
also no longer localized to the Sertoli cell-cell interface to maintain the TJ-barrier function. Instead, it was 
internalized into the cell cytosol, thereby destabilizing the TJ-barrier function. Sertoli cell nuclei were visualized 
by DAPI. Scale bar, 30 μm.
www.nature.com/scientificreports/
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Figure 3. Akt activator SC79 blocks PFOS-mediated Sertoli cell TJ-barrier disruption and mis-localization of TJ and 
basal ES proteins at the BTB. (A) Sertoli cells cultured at 0.1 × 106 cells/cm2 (in 6-well dishes with 2 ml F12/DMEM 
per well) for 3 days were pre-treated with SC79 at 2 μg/ml (5.5 µM) for 30 min. Cells were rinsed and treated with 
50 μM PFOS for 24 hr for immunoblotting. SC79 was found to up-regulate the PFOS-induced down-regulation of 
p-Akt1 T308 and p-Akt1 S473, but had no apparent effect in blocking the PFOS-induced down regulation of p-Akt2 
S474. SC79 was also found to rescue PFOS-induced down-regulation on the expression of ZO-1, palladin. Actin 
served as a loading control. Composite analyzed data of immunoblottings are shown in Figure S2A; and uncropped 
blots are shown in Figure S5. (B) A study by TER to assess the ability of SC79 to block the PFOS-mediated disruption 
of the Sertoli cell TJ-permeability barrier function. Treatment of PFOS alone perturbed the TJ-barrier function, 
**P < 0.01, by Student’s t-test compared between PFOS treated cells vs. control (DMSO) cells; **P < 0.01, by Student’s 
t-test compared between PFOS + SC79-treated cells vs. PFOS-treated cells. (C) Sertoli cells cultured at 0.04 × 106 cells/cm2  
for 3 days were pre-treated with 2 μg/ml SC79 for 30 min, and then cells were rinsed and treated with 20 μM PFOS for 
24 hr. Thereafter, cells were then fixed and examined by immunofluorescence microscopy. SC79 treatment was found 
to block PFOS-induced mis-localization of TJ proteins CAR and ZO-1, as well as basal ES proteins N-cadherin and 
β-catenin. BTB-associated proteins at the Sertoli cell-cell interface in control and PFOS-treated cells were annotated 
by corresponding white and yellow brackets, respectively. Composite analyzed data of this experiment are shown in 
Figure S2B. Sertoli cell nuclei were visualized by DAPI. Scale bar, 30 μm.
www.nature.com/scientificreports/
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distribution across the cell cytosol as found in PFOS-treated cells alone (Fig. 4). These changes thus contributed to 
the re-organization of actin microfilaments so that SC79 rescued PFOS-mediated F-actin disorganization (Fig. 4).
PFOS dose-dependently mediates disorganization of microtubules (MTs). Treatment of Sertoli 
cells with PFOS was found to cause disorganization of MTs when α-tubulins (the building blocks of MTs) across 
the Sertoli cell cytosol were visualized by IF (Fig. 5). For instance, MTs no longer stretched across the cell cytosol 
as found in control cells (DMSO alone) but retracted closer to the cell nuclei when PFOS was used at 20 µM. At 
50 µM, even more MTs were retracted to the cell nuclei (Fig. 5). Furthermore, detyrosinated α-tubulin (the stabi-
lized form of MTs) no longer radiated from the Sertoli cell nuclei but retracted closer to nuclei when exposed to 
PFOS at 20 µM, and considerably diminished more at 50 µM (Fig. 5), illustrating the dose-dependent disruptive 
effects of PFOS, consistent with the IB findings shown in Fig. 1B. Interestingly, the +TIP (plus-end tracking pro-
tein) EB1 (known to stabilize MTs) also no longer stretched across the cell cytosol by forming aggregates along 
Figure 4. SC79 blocks PFOS-induced disorganization of actin microfilaments by maintaining proper spatial 
expression of actin regulatory proteins in Sertoli cells exposed to PFOS. Sertoli cells cultured at 0.03 × 106 cells/
cm2 for 3 days were pre-treated with 2 μg/ml SC79 (5.5 µM) for 30 min, and then cells were rinsed and treated 
with 20 μM PFOS for 24 hr. Cells were then fixed and visualized by immunofluorescence microscopy. It was 
noted that Sertoli cells exposed to PFOS without pre-treatment with SC79 were grossly disorganized in which 
actin microfilaments were truncated, likely the result of changes in the spatial expression of Arp3 (a branched 
actin polymerization protein), palladin (an actin cross-linking and bundling protein) and p-FAK-Y407 (a 
BTB-associated signaling protein known to promote BTB integrity14). However, pretreatment of Sertoli cells 
with SC79 blocked the PFOS-induced disorganization of actin microfilaments, causing actin microfilaments 
to be organized similar to control cells even in the presence of PFOS for 24 hr. This blocking effect of SC79 on 
PFOS-induced Sertoli cell injury apparently was mediated by maintaining the proper spatial expression of Arp3, 
palladin and p-FAK-Y407 as noted in control cells. Distribution of the target proteins Arp3 and p-FAK-Y407 at 
the cell cortical zone was also quantified by measuring the fluorescence intensity at the Sertoli cell-cell interface 
(see dotted white rectangles in control cells vs. dotted yellow rectangles in PFOS-treated cells), which was the 
average of 4 measurements (i.e., fluorescence intensity) at two opposite ends of a Sertoli cell as annotated by 
the rectangles for each cell. About 70 randomly selected cells in each experiment were quantified with n = 3 
independent experiments. Scale bar, 30 μm, which applies to all other micrographs.
www.nature.com/scientificreports/
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the Sertoli cell MTs as noted in control (DMSO only) cells, but possibly dispersed singularly instead of aggregates 
so that the green fluorescence appeared to be weakened (Fig. 5) since no down-regulation of EB1 was noted fol-
lowing PFOS treatment in Sertoli cells (see Fig. 1B).
SC79 recues PFOS-mediated disruption of MT organization through changes in detyrosinated 
α-tubulin and EB1 distribution. Treatment of Sertoli cells with SC79 also rescued PFOS-induced dis-
ruption of MT organization, in which MTs were found to stretch across the entire cell cytosol from cell nuclei 
instead of retracting from cell peripheries to form round-shaped cells in cells treated with PFOS (20 µM) without 
SC79 (Fig. 6, top panel). This protective effect of SC79 appeared to be mediated by re-distributing detyrosinated 
α-tubulin (a stabilized form of MTs) in the Sertoli cell cytosol, so that detyrosinated α-tubulin that was retracted 
from the cell cytosol in PFOS-treated cells was found to radiate from the Sertoli cell nucleus and stretches further 
Figure 5. PFOS induces disorganization of microtubules (MTs) through its disruptive effects on the localization 
of α-tubulin and detyrosinated α-tubulin, and MT regulatory protein EB1. Sertoli cells cultured for 3 days at 
a density of 0.03 × 106 cells/cm2. Cells were then treated with either 20 or 50 μM PFOS for 24 hr. Thereafter, 
cells were fixed with ice-cold methanol and visualized by immunofluorescence microscopy. In control cells, 
α-tubulin, the building block of MTs, stretched across the entire Sertoli cell to support cell shape and served 
as tracks for intracellular transport and trafficking. Following PFOS treatment, there was a dose-dependent 
retraction of MTs across the cell cytosol wherein MTs no longer stretched across the cytosol but encircled the 
Sertoli cell nuclei instead. Detyrosinated α-tubulin, the stabilized form of MTs, was considerably diminished 
dose-dependently, consistent with findings shown in Fig. 1B. Interestingly, the spatial expression of EB1, a +TIP 
(plus-end tracking protein) was considerably disrupted since it no longer expressed prominently across the 
MTs as noted in control Sertoli cells, but apparently dispersed in the cell cytosol since the overall expression of 
EB1 was not shown to be down-regulated as noted by immunoblotting shown in Fig. 1B. Sertoli cell nuclei were 
visualized by DAPI. Scale bar, 30 μm, which applies to all other micrographs.
www.nature.com/scientificreports/
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into the cell cytosol in SC79 pretreated cells (Fig. 6, second panel). Similarly, EB1, a +TIP, also stretched across 
the Sertoli cell cytosol following SC79 treatment, by preventing PFOS-induced mis-localization of EB1, in which 
EB1 formed aggregates along the MTs to induce MT stabilization in SC79-treated cells even with PFOS exposure, 
considerably different from Sertoli cells treated with PFOS alone (Fig. 6, bottom panel).
Discussion
Findings reported herein are consistent with other data in the literature that cytoskeletons in Sertoli cells, includ-
ing both the F-actin and the microtubule (MT)-based cytoskeletons, are one of the targets of environmental 
toxicants (for reviews, see refs 40–45). Besides Sertoli cells isolated from rodent testes as noted herein, F-actin 
cytoskeleton in human Sertoli cells is also highly susceptible to environment toxicants, such as cadmium chloride 
(CdCl2) and bisphenol A (BPA), which were shown to induce defragmentation of actin microfilaments in Sertoli 
cells, thereby perturbing the distribution of TJ proteins (e.g., ZO-1) and basal ES proteins (e.g., N-cadherin, 
ß-catenin) at the Sertoli cell-cell interface46. In this context, it is of interest to note that CdCl2 remains widely used 
in the United States, such as manufacturing of batteries, and contaminating our environment through municipal 
waste incineration, plus an increase in human uptakes through contaminated water and food supplies including 
cigarette smoking; whereas BPA is found in many household items (e.g., utensils, plastics, food containers) (for 
BPA) (for reviews, see refs 34, 47). While the elimination half-life of BPA is short in humans (<2 hr), but cad-
mium has a half-life of >20 years so that considerable amount of toxic level of cadmium can build up in humans 
over time. Thus, the observation that human Sertoli cells are susceptible to these toxicants is of interest since these 
findings reproduce some of the earlier observations in studies using rodent Sertoli cells, illustrating F-actin organ-
ization is one of the targets of toxicants13, 48. This unexpected disruption of the F-actin organization in Sertoli cells 
induced by toxicants such as PFOS as illustrated herein vs. cadmium and BPA shown earlier is of physiologically 
important, since these findings implicate that the BTB function is compromised in the testis in vivo following 
exposure to toxicants as noted earlier49–53. This also explains earlier observations that the testis is highly vulner-
able to toxicants (e.g., cadmium) as reported six decades ago54, 55. Indeed, subsequent studies confirmed the BTB 
was compromised before changes in the permeability of the microvessels in the testis49 when the kinetics of their 
disruption were assessed56, illustrating while the BTB is one of the tightest blood-tissue barriers (for reviews, see 
refs 20, 57), it is highly susceptible to environmental toxicants when compared to other blood-tissue barriers such 
as the endothelial TJ-barrier. Studies in recent years have also cautioned a declining trend of semen quality and/or 
sperm counts in men is associated with an increase in environmental toxicant exposure58, 59. Perhaps, this is due 
Figure 6. Akt activator SC79 blocks PFOS-mediated MT (e.g., α-tubulin and detyrosinated α-tubulin) 
disorganization by attenuating disruptive distribution of EB1. Sertoli cells cultured for 3 days at a density of 
0.03 × 106 cells/cm2. Cells were pre-treated with 2 μg/ml SC79 (5.5 µM) for 30 min, and then cells were rinsed 
and treated with PFOS at 20 µM for 24 hr. Thereafter, cells were fixed with ice-cold methanol and visualized 
by immunofluorescence microscopy using corresponding antibodies (Table 1). Consistent with data shown in 
Fig. 5, PFOS induced disorganization of MTs by disrupting the organization of α-tubulin and detyrosinated 
α-tubulin across the Sertoli cell cytosol and also +TIP EB1. However, SC79 blocked the PFOS-mediated MT 
disorganization, possibly by attenuating disruptive distribution of EB1 in SC79 pre-treated cells. Sertoli cell 
nuclei were visualized by DAPI. Scale bar, 30 µm, which applies to all other micrographs.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 1110  | DOI:10.1038/s41598-017-01016-8
to the readily disrupted BTB, this thus increases the bioavailability of the toxicant in the testis behind the BTB, 
exposing post-meiotic spermatids to the toxicant.
Thus, it is important to identify the signaling molecule(s) mediated by toxicants through which the BTB can 
be modulated. Akt (also known as PKB) is a Ser/Thr protein kinase composed of three closely related and widely 
expressed isoforms of Akt1, Akt2 and Akt3 found in virtually all mammalian cells (for reviews, see refs 60, 61) 
including Sertoli cells21. In fact, Akt/PKB is prominently expressed at the ES (a testis-specific actin-rich anchoring 
junction found at the Sertoli cell-cell interface at the BTB known as basal ES vs. the similar ultrastructure found 
at the Sertoli cell-spermatid interface known as apical ES in the adluminal (apical) compartment of the seminif-
erous epithelium (for reviews, see refs 62, 63)) in the adult rat testis21. As reported herein, Akt1/2 was shown to be 
a putative target of PFOS. First, treatment of Sertoli cells with an established functional TJ-barrier was found to 
perturb the barrier function, associated with a down-regulation on the expression of p-Akt1-T308, p-Akt1-S473, 
and p-Akt2-S474. Second, the use of SC79, an Akt activator, was found to restore the steady-state protein level 
of p-Akt1-T308 and p-Akt1-S473, but had no apparent effect on p-Akt2-S474. These findings thus illustrate that 
PFOS-induced p-Akt2-S474 down-regulation could not be rescued by SC79, and this down-regulation had no 
correlation with PFOS-induced Sertoli cell TJ-barrier disruption nor the underlying cytoskeletal disorganization. 
It is known that p-Akt1-T308 and p-Akt1-S473 are working in concert to modulate cellular functions64. In fact, 
modification of Akt1 at T308 and S473 via phosphorylation has been established as the equivalent of Akt acti-
vation, illustrating these two sites are working in concert to modulate cellular function (for a review, see ref. 60). 
Thus, our findings that PFOS-induced p-Akt1-T308 and p-Akt1-S473 inactivation via their down-regulation, 
and a restoration of the leaky BTB by SC79 through an up-regulation of Akt1 at these two sites are consistent with 
the earlier reports60, 65. An interesting observation in this report is the finding that the use of SC79 was shown to 
induce re-organization of both F-actin- and MT-based cytoskeletons, making the PFOS-treated cells more simi-
lar to control cells, blocking the disruptive effects of PFOS on the organization of actin microfilaments and MTs. 
Since all the TJ- and basal ES-proteins are actin-based adhesion protein complexes, the re-establishment of the 
F-actin cytoskeleton thus provides the platform for re-distribution of these BTB-associated proteins so that the 
TJ-barrier function can be restored.
In this context, it is of interest to note that treatment of Sertoli cells with SC79 alone was found to up-regulate 
p-Akt1-T308 and p-Akt1-S473 (but not p-Akt2/S474), consistent with the concept that p-Akt1-T308 and 
p-Akt1-S473 are working together to regulate cell function64, yet SC79 alone had no apparent effects on the 
Sertoli cell TJ-permeability barrier. These observations thus suggest that there are other proteins and/or sign-
aling pathways involved in modulating the SC79-mediated rescue efforts following PFOS exposure regarding 
re-organization of the actin- and MT-based cytoskeletons. This notion is supported by studies demonstrating that 
overexpression of connexin 43 (Cx43, a gap junction protein highly expressed in the testis66, 67 and a target of envi-
ronmental toxicant67) also intercepts the PFOS-induced BTB disruption and capable of rescuing PFOS-mediated 
F-actin disorganization36. For instance, in the absence of PFOS, Cx43 per se that is known to maintain the Sertoli 
cell TJ-permeability barrier function68, 69 might have conferred the TJ-barrier function to its maximal, thus, the 
presence of SC79, including the activation of p-Akt1-T308 and p-Akt1-S473 could no longer enhance the immu-
nological barrier to make it “tighter”. This possibility, however, must be carefully evaluated in future studies.
Earlier studies have shown that FAK, in particular p-FAK-Y407 is an important signaling molecule tightly 
involved in BTB integrity, playing a role in the organization of actin-based cytoskeleton in Sertoli cells14, 70. Studies 
in other mammalian cells have shown that FAK is the upstream signaling protein of Akt71, 72, and these two signal-
ing proteins often work as close partners to modulate a number of cellular functions in particular tumorigenesis73. 
In fact, we also report herein the use of SC79 could restore the spatial expression of p-FAK-Y407 in Sertoli cells 
disrupted by PFOS, suggesting that these two functional signaling kinases may indeed work together to modulate 
Sertoli cell BTB function. This possibility should be carefully evaluated in future studies.
In summary, we have demonstrated unequivocally that PFOS-mediated Sertoli cell BTB disruption can be 
rescued by the use of an Akt activator SC79, which apparently exerts its effects by re-establishing the underlying 
actin- and MT-based cytoskeletons, restoring the localization of BTB-associated adhesion protein complexes. 
This thus reseals the disrupted Sertoli cell TJ-permeability barrier induced by PFOS. These findings should be 
carefully evaluated and further expanded to include the use of human Sertoli cells to assess if an activation of 
p-Akt could rescue PFOS-mediated Sertoli cell injury since a recent report has shown that Sertoli cell injury 
induced by environmental toxicants is similar to Sertoli cells isolated from rodent testes46. This additional study 
should be of important to therapeutically manage PFOS (or other environmental toxicants) induced testis injury 
and possibly infertility.
Materials and Methods
Animals and antibodies. Male Sprague-Dawley pups at 16–19 days of age, with a foster mother per 10 
pups, were purchased from Charles River Laboratories (Kingston, NY). Animals were housed at the Rockefeller 
University Comparative Bioscience Center (CBC) with 10 pups and a foster mother per cage. All animals had 
free access to standard rat chow and water ad libitum under controlled temperature (22 °C) and constant light-
dark cycles (12 hr of light: 12 hr of darkness). These animals were maintained in accordance with the applicable 
portions of the Animal Welfare Act and the guidelines in the Department of Health and Human Services pub-
lication Guide for the Care and Use of Laboratory Animals. The use of rats for experiments reported herein was 
approved by the Rockefeller University Institutional Animal Care and Use Committee (IACUC) with Protocol 
Numbers 12–506 and 15–780-H. All methods and experimental protocols used for relevant studies reported 
herein, including the use of animals and primary Sertoli cell cultures were carried out in accordance with the rele-
vant guidelines, including any relevant details, and approved by the Rockefeller University Laboratory Safety and 
Environmental Health, the Rockefeller University Institutional Biosafety Committee (IBC), and the Rockefeller 
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University Comparative Bioscience Center (CBC). These methods were also described in details in the sections 
below. Antibodies were obtained commercially and listed in Table 1.
Primary Sertoli cell cultures. Sertoli cells were isolated from the testes of 20-day-old rats as earlier 
described19. Cells were seeded on Matrigel (1:5–1:7, diluted in F12/DMEM; BD Biosciences, San Jose, CA)-coated 
Millipore Millicell HA bicameral units (12-mm diameter, 0.6-cm2 effective surface area; 0.45-µm pore size; each 
unit was placed on a well of a 24-well dish containing 0.5 ml F12/DMEM in the apical and basal compartment), 
6-well culture dishes (with each well contained 2 ml F12/DMEM to be used for lysate preparation) or covers-
lips (with each coverslip place on the well of a 12-well dish containing 1 ml F12/DMEM for immunofluores-
cence (IF) analysis) at densities of 1, 0.1 and ~0.03–0.04 × 106 cells/cm2, respectively. Sertoli cells were cultured 
in serum-free F12/DMEM (Thermo Fisher Scientific, Waltham, MA) supplemented with growth factors and 
gentamicin and incubated in a humidified atmosphere of 95% air/5% CO2 (v/v) at 35 °C as described19. On day 
2, Sertoli cells were subjected to a brief hypotonic treatment with 20 mM Tris (pH 7.4) for 2.5 min to lyse residual 
germ cells74, and replaced with fresh medium containing antibiotics and supplements. These Sertoli cell cultures 
contained ~98% Sertoli cells, with negligible contaminations of Leydig cells, peritubular myoid cells, and/or germ 
cells when specific markers of these cell types were used to assess their contamination by either immunoblotting 
(IB) or RT-PCR as described75. Sertoli cells cultured in vitro were shown to establish a functional TJ-permeability 
barrier with ultrastructures of TJs, basal ESs, gap junctions, and desmosomes that mimic the Sertoli cell BTB in 
vivo as described21, 52.
Treatment of Sertoli  cells  with perfluorooctanesulfonate (PFOS) and SC79. 
Perfluorooctanesulfonate (PFOS) was obtained from Sigma-Aldrich (St. Louis, MO) and dissolved in DMSO 
at 100 mM. SC79 (2-amino-6-chloro-α-cyano-3-(eethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester, 
Mr 364.78), a specific Akt1/2 activator that binds to the plecktrin homology (PH) domain of Akt, mimicking the 
binding of PtdIns(3,4,5)P3 to induce Akt conformational change that enhances phosphorylation and activation at 
both the p-Akt1-T308 and p-Akt1-S473 sites39, was purchased from Millipore (Billerica, MA). SC79 was freshly 
prepared at 25 μg/μl in DMSO. Sertoli cells cultured for 3 days was treated with DMSO (control) vs. 10, 20 or 
50 μM PFOS for 24 hr. For the rescue experiments, Sertoli cells were pre-treated with 2 μg/ml SC79 (5.5 µM) for 
30 min as earlier described39, and then cells were rinsed and treated with PFOS (20 μM for IF; 50 μM for IB) for 
24 hr. The same amount of DMSO was used in controls. The approach of pretreating cells with SC79 to examine 
its effects on Akt signaling was similar to earlier reports39, 76. However, in the experiments where the effects of 
SC79 to attenuate PFOS-mediated Sertoli cell TJ-barrier disruption were investigated, besides pre-treating cells 
with SC79 for 30 min, SC79 was also included during treatment of cells with PFOS for 24 hr. The selected con-
centrations of PFOS used in our experiments were based on earlier studies13, 23, 77, and were earlier shown to have 
no detectable cytotoxicity in Sertoli cells13. The concentration of SC79 used in our studies was similar to earlier 
studies on mammalian cells and tissues both in vitro and in vivo without cytotoxicity39, 78.
Lysate preparation and immunoblotting (IB). Protein lysates from primary Sertoli cells were obtained 
using IP lysis buffer [50 mM Tris, 0.15 M NaCl, 1% NP-40, 2 mM EGTA, and 10% glycerol (v/v), pH 7.4 at 22 °C] 
supplemented with protease phosphatase inhibitor mixture (Sigma-Aldrich) and phosphatase inhibitor mixture 
II (Sigma-Aldrich). Protein concentration was determined using a DC Protein Assay Kit from Bio-Rad (Hercules, 
CA). About 25–40 µg protein was used from each sample for immunoblotting. In short, equal amount of protein 
lysate from all samples within an experiment were resolved by SDS-PAGE and transferred onto nitrocellulose 
membrane (Bio-Rad) for immunoblot analysis using the corresponding primary and secondary antibody for 
a target protein (Table 1). Each target protein was visualized by enhanced chemiluminescence using a kit pre-
pared in our laboratory as described79. Digital images were acquired and quantified using a Fujifilm LAS-4000 
mini-Luminiscent Image Analyzer and Multi Gauge software package (Version 3.1) from Fujifilm Corp (Valhalla, 
NY) as earlier reported35. Due to space limitation to display multiple immunoblots, blots were cropped to illus-
trate only the target proteins to compare changes between treatment and control groups, and full-length blots for 
blots reported in Fig. 1B and Fig. 3A are shown in Figures S4 and S5, respectively, in Supplementary Information.
Immunofluorescence (IF) analysis. IF was performed using Sertoli cells cultured on coverslips at a den-
sity of ~0.03–0.04 × 106 cells/cm2. Sertoli cells were fixed in 4% PFA in PBS (10 mM sodium phosphate, 0.15 M 
NaCl, pH 7.4 at 22 °C) or ice-cold methanol, permeabilized with 0.1% Triton X-100 in PBS, and subsequently 
blocked with 1% BSA in PBS. Cells were then incubated with the corresponding primary antibodies (Table 1) 
at 4 °C overnight, to be followed by Alexa Fluor 488 (green) secondary antibodies (Thermo Fisher Scientific) 
for 1 hr. To visualize F-actin, sections and/or cells were incubated with FITC-conjugated phalloidin (Thermo 
Fisher Scientific) at 1:50 dilution for 1 hr. Cells on microscopic slides were mounted in Prolong Gold Antifade 
reagent with 4′, 6-diamidino-2-phenylindole (DAPI, Life Technologies) to visualize cell nuclei. Fluorescence 
images were examined and acquired using a Nikon Eclipse 90i Fluorescence Microscope system equipped with a 
Nikon Ds-Qi1Mc and a Nikon DS-Fi1 digital cameras, using the Nikon NIS Elements Imaging Software (Nikon 
Instruments, Inc). Image files were then analyzed using Photoshop in Adobe Creative Suite (Version 3.0; San 
Jose, CA) for image overlay to assess protein co-localization. All Sertoli cells within an experimental group were 
processed simultaneously in a single experimental session to eliminate interexperimental variations and each 
experiment was repeated at least 3 times. To assess changes in protein expression and/or distribution following 
treatment with DMSO by immunofluorescence microscopy, fluorescence intensity at the Sertoli cell-cell interface 
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of a target protein in control vs. treatment group (at two opposite ends of adjacent cells, i.e., 4 measurements, to 
obtain an average which was the mean fluorescence intensity) in in vitro experiments was quantified using ImageJ 
1.45 software (NIH, Bethesda, MD; http://rsbweb.nih.gov/ij). For changes in protein localization near the Sertoli 
cell cortical zone, the distribution of fluorescence signals at the cell-cell interface was measured at the two oppo-
site ends (i.e., 4 measurements) of the Sertoli cell nucleus, which was then averaged to obtain the mean width. At 
least 200 cells were randomly selected and examined in control vs. experimental groups with n = 3 experiments 
(i.e., ~70 randomly selected cells per experiment).
Monitoring the Sertoli cell TJ-permeability barrier function in vitro. Sertoli cells were plated on 
Matrigel (1:5)-coated bicameral units at 1 × 106 cells/cm2. Bicameral units were then placed in 24-well plates 
with 0.5 ml F12/DMEM each in the apical and basal compartment. To assess the TJ-permeability barrier, both 
the PFOS and the control (DMSO) group contained triplicate bicameral units, and TER (transepithelial electrical 
resistance) across the cell epithelium was recorded daily. It is noted that TER monitored the ability of the Sertoli 
cell epithelium on the bicameral unit to resist conductivity of an electrical current that was sent across the elec-
trodes of the Millipore Millicell ERS system as described19. Blanks contained Matrigel-coated bicameral units 
without Sertoli cells. TER experiments were repeated at least 3 times using different batches of Sertoli cells and 
yielded similar results.
Statistical analysis. For studies using Sertoli cell cultures, triplicate coverslips, wells, or bicameral units were 
used for each experiment including treatment and control groups. Each data point (or bar graph) is a mean ± SD 
of n = 3 to 5 experiments. Statistical analysis was performed by one-way ANOVA followed by Dunnett’s test or 
nonparametric Mann-Whitney U test. In selected experiments, Student’s t-test was used for paired comparisons. 
Statistical analysis was performed using the GB-STAT software package (Version 7.0; Dynamic Microsystems, 
Silver Spring, MD). Mann-Whitney U test was performed using GraphPad Prism (Version 5.0, GraphPad 
Software, La Jolla, CA). P < 0.05 or smaller was considered statistically significant.
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